Announcement
23 Oct 2026
: M42 and Inocras announce strategic collaboration to advance earlier detection of cancer recurrence in the UAE using whole genome powered MRD technology
Learn More

Driving Precision Medicine through Proteomics & Metabolomics - Future of Healthcare in UAE

20 February 2025
Genomics and Precision Medicine
Arab Health 2025

About the Speakers

  • Paul Jones
    Chief Executive Officer, Omics Centre of Excellence

    Paul Jones, CEO of M42’s Omics Centre of Excellence, drives advancements in genomics and precision medicine with 30+ years of experience in global genomic programs and personalized health solutions.

  • Dr. Vidya Velagapudi
    Senior Vice President, Precision Medicine and Academy of Education & Research, Global Patient Care platform, M42

    Watch Next